Skip to main content
. 2024 Dec 28;14:30767. doi: 10.1038/s41598-024-80834-z

Fig. 2.

Fig. 2

DAC-mediated mtRNA upregulation limits its antiproliferative effects. (A) Glycolytic and mitochondrial ATP content in DMSO or DAC-treated cells was analyzed by Cell Titer Glo. Oligomycin A was used to distinguish the glycolytic ATP from total ATP which was then used to calculate the mitochondrial ATP levels. (B, C) mtDNA copy number (B) or mt-mRNA (C) expression in DMSO or DAC-treated cells analyzed by RT-qPCR. (D) The protein expression of COX1 in DMSO or DAC-treated cells analyzed by western blotting. (E) The expression of POLRMT mRNA in DMSO or DAC-treated cells analyzed by RT-qPCR. (F) Glycolytic and mitochondrial ATP of HCT116 cells treated with DAC measured using Cell Titer Glo. (G) RT-qPCR analysis of mt-mRNA expression in DMSO and DAC-treated HCT116 cells. (H) Western blotting of apoptosis-associated proteins, BCL-2, and NF-κB signaling pathway-associated genes in DMSO and DAC-treated A549 and HCT116 cells. In all experiments, an average of three biological replicates is shown with error bars denoting s.e.m. A Student’s t-test was performed for statistical analysis. * indicates P-value < 0.05, ** indicates P-value < 0.01, *** indicates P-value < 0.001.